Toggle Main Menu Toggle Search

Open Access padlockePrints

Clinical Spectrum and Therapy of Non-Alcoholic Steatohepatitis

Lookup NU author(s): Professor Chris Day

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Non-alcoholic fatty liver disease is increasingly being diagnosed worldwide and considered to be the commonest liver disorder in Western countries. It comprises a disease spectrum ranging from simple steatosis (fatty liver) through nonalcoholic steatohepatitis (NASH) to fat with fibrosis and, ultimately, cirrhosis. Simple steatosis is largely benign and non-progressive, whereas NASH can lead to cirrhosis, liver failure and hepatocellular carcinoma. Therapeutic strategies can be divided into those directed at components of the metabolic syndrome with potential beneficial liver effects and those directed specifically at the liver. Recent data suggest that diet and exercise improve NASH, particular in those achieving >7% weight loss. Obesity surgery has been shown to improve steatosis in all studies and inflammation and fibrosis in some. With respect to anti-diabetic drugs, results for metformin have not been convincing and concerns over the safety of glitazones have reduced the initial enthusiasm for their use. ACE inhibitors and angiotensin II receptor blockers hold the most promise as anti-hypertensive agents for patients with NASH and hypertension. With respect to more specific liver-directed therapies, there have been promising studies of antioxidants, including betaine and probucol, and vitamin E may improve NASH in adults and children. The TNF-alpha-lowering agent pentoxifylline may have beneficial effects on NASH. Liver transplantation is successful, but the disease recurrence rate is high in the absence of treatment of the underlying metabolic syndrome. Copyright (C) 2012 S. Karger AG, Basel


Publication metadata

Author(s): Day CP

Publication type: Article

Publication status: Published

Journal: Digestive Diseases

Year: 2012

Volume: 30

Pages: 69-73

Print publication date: 11/10/2012

ISSN (print): 0257-2753

ISSN (electronic): 1421-9875

Publisher: S. Karger AG

URL: http://dx.doi.org/10.1159/000341128

DOI: 10.1159/000341128


Altmetrics

Altmetrics provided by Altmetric


Share